The class of chemicals identified as potential activators for FAM90A18 encompasses a diverse array of compounds known for their roles in modulating key cellular processes. These activators, while not directly linked to FAM90A18, are selected based on their influence on cellular pathways that could indirectly impact the activity of FAM90A18.The first category includes agents like Forskolin and 5-Azacytidine, which modulate intracellular signaling and gene expression. Forskolin, by elevating cAMP levels, can activate various downstream pathways that may intersect with the functional domain of FAM90A18. Similarly, 5-Azacytidine's impact on DNA methylation patterns could lead to changes in gene expression profiles, potentially influencing the expression or function of FAM90A18.
Histone deacetylase inhibitors such as Trichostatin A and Sodium Butyrate represent another category. By altering chromatin structure and gene expression, these compounds can modify the cellular context in which FAM90A18 operates, potentially leading to changes in its activity. Additionally, compounds like Rapamycin and SB431542, which target mTOR and TGF-β pathways respectively, demonstrate the complexity of cellular signaling networks and their potential to indirectly modulate the activity of less characterized proteins like FAM90A18.Overall, this chemical class highlights the intricate interplay of various signaling molecules and pathways within the cell, underscoring the potential for indirect modulation of protein activity through targeted chemical intervention. While direct activators of FAM90A18 are not identified, these compounds provide valuable insights into possible mechanisms of action for influencing the activity of such proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, affecting gene expression which could indirectly impact FAM90A18 activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferase, altering gene expression, potentially affecting FAM90A18. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of protein synthesis and cell growth, which might influence FAM90A18. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, affecting numerous signaling pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences glycogen synthase kinase 3 (GSK-3) activity, impacting signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences gene expression via retinoic acid receptors, potentially affecting FAM90A18. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate various signaling pathways and transcription factors. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins and has broad effects on cellular signaling. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor, impacting gene expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β receptor, affecting related signaling pathways. | ||||||